125 related articles for article (PubMed ID: 1881673)
1. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of azithromycin against Chlamydia trachomatis.
Scieux C; Bianchi A; Chappey B; Vassias I; Pérol Y
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():7-10. PubMed ID: 2154440
[TBL] [Abstract][Full Text] [Related]
3. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
Korting HC; Hartinger A
Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
[TBL] [Abstract][Full Text] [Related]
4. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Dailloux M; Villemain P
Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
7. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of in vitro activity of rokitamycin against Chlamydia trachomatis].
Bannai H; Miyano A; Miyazawa H; Ashihara Y
Kansenshogaku Zasshi; 1990 Jun; 64(6):687-92. PubMed ID: 2401815
[TBL] [Abstract][Full Text] [Related]
10. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
14. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
Crotti D; Rossetti R; Braga PC
Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
[TBL] [Abstract][Full Text] [Related]
17. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
Braga PC; Culici M; Dal Sasso M
Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological study of Chlamydia trachomatis infection in a sample of women requesting voluntary termination of pregnancy, treated with rokitamycin].
Carta E; Marletta A; Artuso A; Chiodi S; Consoli R; Fasce V; Paccagnella F; Palmonella G; Spinelli S; Guerini Rocco C
Minerva Ginecol; 2000; 52(1-2):33-9. PubMed ID: 10851862
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
Kanamoto Y; Miyake Y; Suginaka H; Usui T
Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
